Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Biomx Ltd (PHGE)

Biomx Ltd (PHGE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Biomx Ltd 850 New Burton Road Suite 201 Dover L3 19904 ISR

www.biomx.com Employees: 20 P: 972-54-561-0935

Sector:

Medical

Description:

BiomX Ltd is a clinical stage microbiome company. It engages in developing both natural and engineered phage cocktails designed to target and destroy bacteria which affect the appearance of skin, as well as harmful bacteria in chronic diseases, such as IBD, PSC and cancer. BiomX Ltd, formerly known as Chardan Healthcare Acquisition Corp., is based in Ness Ziona, Israel.

Key Statistics

Overview:

Market Capitalization, $K 4,765
Enterprise Value, $K 18,425
Shares Outstanding, K 1,594
Float, K 1,246
% Float 78.20%
Short Interest, K 93
Short Float 5.85%
Days to Cover 1.00
Short Volume Ratio 0.49
% of Insider Shareholders 21.80%
% of Institutional Shareholders 40.57%

Financials:

Annual Sales, $ 0 K
Annual Net Income, $ -36,200 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -13,340 K
EBIT, $ -30,930 K
EBITDA, $ -28,010 K

Growth:

1-Year Return -71.33%
3-Year Return -94.32%
5-Year Return -99.75%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 91.02%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -5.51 on 11/12/25
Next Earnings Date 05/21/26
Earnings Per Share ttm -8.17
EPS Growth vs. Prev Qtr -252.63%
EPS Growth vs. Prev Year 70.10%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-19 on 11/25/25

PHGE Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % -83.44%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share -0.82
Interest Coverage -1,808.50
60-Month Beta 1.69
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.